search results for 
Logo

Group sales and earnings

With its international production and sales platform and its market-oriented products and services, the Fresenius Group is well positioned for continued growth in the coming years. Specific opportunities for profitable growth are indicated by the developments described in the section “Health Care Sector and Markets”. In 2012, we therefore expect to increase Group sales by 10% to 13% in constant currency.

While our traditional markets in Europe and North America are growing at average low to mid-single-digit rates, we see stronger growth potential in the Asia-Pacific region and in Latin America. Here the demand for our life-saving and life-sustaining products continues to be high as access to medical care is still limited. This will also be reflected in sales.

We expect to increase Group net income once again in 2012. We aim to achieve this through the growth in sales discussed and by ongoing measures to optimize costs. Despite a market environment which continues to be marked by cost containment and price pressure, we expect to increase net income by 8% to 11% in constant currency.

GROUP FINANCIAL TARGETS


  Targets 2012 Fiscal year 2011
1 Net income attributable to Fresenius SE & Co. KGaA; 2011 adjusted for special items relating to the acquisition of APP Pharmaceuticals.
Sales growth (in constant currency) 10% – 13% €16,522 m
Net income1, growth (in constant currency) 8% – 11% €770 m
Capital expenditure ~ 5% of sales €783 m
Dividend Profit-driven dividend policy Proposal: + 10% per ordinary share

  Targets 2012 Fiscal year 2011
1 Net income attributable to Fresenius SE & Co. KGaA; 2011 adjusted for special items relating to the acquisition of APP Pharmaceuticals.
Sales growth (in constant currency) 10% – 13% €16,522 m
Net income1, growth (in constant currency) 8% – 11% €770 m
Capital expenditure ~ 5% of sales €783 m
Dividend Profit-driven dividend policy Proposal: + 10% per ordinary share

We have set ourselves a new mid-term target and plan to achieve average organic sales growth of 6% to 9% p. a. for the Group. We also have set ourselves an ambitious earnings goal. We aim to achieve Group net income of more than €1 billion by 2014.

QUICKFINDER

History

Tools